| 6400- | ANE, | FEO, | A comprehensive review of the neurological effects of anethole |
| - | Review, | AD, | NA |
| 6401- | ANE, | Anethole and Its Role in Chronic Diseases |
| - | Review, | Var, | NA | - | Review, | PSA, | NA |
| 6402- | ANE, | FEO, | trans-Anethole of Fennel Oil is a Selective and Nonelectrophilic Agonist of the TRPA1 Ion Channel |
| - | in-vitro, | Nor, | HEK293 |
| 6404- | ANE, | Anethole induces apoptotic cell death accompanied by reactive oxygen species production and DNA fragmentation in Aspergillus fumigatus and Saccharomyces cerevisiae |
| - | in-vitro, | Var, | NA |
| 6405- | ANE, | Anethole inhibits human U87 Glioma cell proliferation by inducing apoptosis via the PI3K/AKT pathway |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
| 6406- | ANE, | Anethole induces anti-oral cancer activity by triggering apoptosis, autophagy and oxidative stress and by modulation of multiple signaling pathways |
| - | in-vitro, | Oral, | Ca9-22 |
| 6403- | ANE, | Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease |
| - | in-vivo, | Nor, | NA |
| 6889- | Ang, | Inhibition of Acetylcholinesterase by Extracts and Constituents from Angelica archangelica and Geranium sylvaticum |
| - | in-vitro, | AD, | NA |
| 6888- | Ang, | Uncovering the Mechanisms of Angelica glauca Edgew. In Breast Cancer: A Combined In Vitro and In Silico Approach |
| - | in-vitro, | BC, | MCF7 |
| 6887- | Ang, | Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development |
| - | in-vivo, | BC, | 4T1 | - | in-vitro, | BC, | MCF7 |
| 4746- | antiOx, | Chemo, | VitA,RetA, | VitC, | Se | Using Supplements During Chemo: Yes or No? |
| - | Review, | Var, | NA |
| 4758- | antiOx, | Chemo, | Therapeutic controversies over use of antioxidant supplements during cancer treatment: a scoping review |
| - | Review, | Var, | NA |
| 4759- | antiOx, | Chemo, | Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization |
| - | Review, | Var, | NA |
| 4760- | antiOx, | Chemo, | Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials |
| - | Review, | Var, | NA |
| 4765- | antiOx, | Chemo, | Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity |
| - | Review, | Var, | NA |
| 7839- | AO, | ISQ, | The Protective Effects of Acer okamotoanum and Isoquercitrin on Obesity and Amyloidosis in a Mouse Model |
| - | in-vivo, | AD, | NA | - | in-vivo, | Obesity, | NA |
| 7907- | Api, | IVT, | Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells |
| - | Review, | Var, | NA |
| 7815- | Api, | LT, | NarG, | QC, | MOR | The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review |
| - | Review, | AD, | NA |
| 1301- | Api, | Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways |
| - | in-vitro, | neuroblastoma, | NA |
| 1149- | Api, | Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling |
| - | vitro+vivo, | IBD, | NA |
| 1150- | Api, | Apigenin inhibits the TNFα-induced expression of eNOS and MMP-9 via modulating Akt signalling through oestrogen receptor engagement |
| - | in-vitro, | Lung, | EAhy926 |
| 1151- | Api, | Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | 22Rv1 | - | in-vivo, | NA, | NA |
| 1152- | Api, | Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? |
| - | Analysis, | Nor, | NA |
| 1999- | Api, | doxoR, | Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation |
| - | in-vitro, | Nor, | NRK52E | - | in-vitro, | Nor, | MPC5 | - | in-vitro, | BC, | 4T1 | - | in-vivo, | NA, | NA |
| 1546- | Api, | Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis of Animal Models |
| - | Review, | Var, | NA |
| 1557- | Api, | Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement |
| - | in-vitro, | Nor, | NA |
| 1556- | Api, | Dissolution and antioxidant potential of apigenin self nanoemulsifying drug delivery system (SNEDDS) for oral delivery |
| - | Analysis, | Nor, | NA |
| 1555- | Api, | USDA Database for the Flavonoid Content of Selected Foods |
| - | Analysis, | Nor, | NA |
| 1554- | Api, | A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota |
| - | Review, | Nor, | NA |
| 1553- | Api, | Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy |
| - | Review, | Var, | NA |
| 1552- | Api, | Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p |
| - | in-vitro, | CRC, | HCT116 |
| 1551- | Api, | Chemotherapeutic effects of Apigenin in breast cancer: Preclinical evidence and molecular mechanisms; enhanced bioavailability by nanoparticles |
| - | Review, | BC, | NA |
| 1550- | Api, | Formulation and characterization of an apigenin-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential |
| - | Analysis, | Nor, | NA |
| 1549- | Api, | Chemo, | Chemoprotective and chemosensitizing effects of apigenin on cancer therapy |
| - | Review, | Var, | NA |
| 1548- | Api, | A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms |
| - | Review, | Colon, | NA |
| 1547- | Api, | Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading |
| - | Review, | Var, | NA |
| 1565- | Api, | Apigenin-7-glucoside induces apoptosis and ROS accumulation in lung cancer cells, and inhibits PI3K/Akt/mTOR pathway |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | BEAS-2B | - | in-vitro, | Lung, | H1975 |
| 1545- | Api, | The Potential Role of Apigenin in Cancer Prevention and Treatment |
| - | Review, | Var, | NA |
| 1544- | Api, | The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68 |
| - | in-vitro, | Nor, | WRL68 |
| 1543- | Api, | Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms |
| - | Review, | Var, | NA |
| 1542- | Api, | Bioavailability of Apigenin from Apiin-Rich Parsley in Humans |
| - | Human, | Nor, | NA |
| 1541- | Api, | EGCG, | Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence |
| - | Human, | CRC, | NA |
| 1540- | Api, | Determination of Total Apigenin in Herbs by Micellar Electrokinetic Chromatography with UV Detection |
| - | Analysis, | Nor, | NA |
| 1539- | Api, | LT, | Dietary flavones counteract phorbol 12-myristate 13-acetate-induced SREBP-2 processing in hepatic cells |
| - | in-vitro, | Liver, | HepG2 |
| 1538- | Api, | Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: In vitro and in vivo evaluations |
| - | in-vivo, | Nor, | NA |
| 1537- | Api, | Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer |
| - | Review, | PC, | NA |
| 1536- | Api, | Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells |
| - | in-vitro, | MM, | MSTO-211H | - | in-vitro, | MM, | H2452 |
| 1559- | Api, | Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 1560- | Api, | Apigenin as an anticancer agent |
| - | Review, | Var, | NA |
| 1564- | Api, | Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation |
| - | in-vitro, | Pca, | 22Rv1 | - | in-vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid